साइटोमेगालोवायरस रेटिनाइटिस का प्रथम-पंक्ति उपचार

References

DOI: 10.3390/v16091427

• Initial treatment typically involves first-line drugs like ganciclovir (GCV), valganciclovir (VGCV), cidofovir (CDV), and foscarnet (FOS).
• GCV is the first-line treatment for CMV, offering various administration routes including oral, intravenous, vitreous, and intraocular implants.
• Research has shown that a twice-daily dose of 900 mg of oral VGCV for induction therapy in CMVR patients has an efficacy and safety profile comparable to that of intravenous ganciclovir.
• After 2 weeks of anti-cytomegalovirus therapy, retinal necrotic lesion has disappeared on fundus photograph, OCT showed subretinal fluid absorption and the edema of the necrotic lesion relief.